期刊文献+

顺铂诱导颊癌细胞凋亡及凋亡分子(Apo-1)表达的实验研究 被引量:3

Experimental Study on Apoptosis and Apo 1 Expression \;of Buccal Carcinoma Cell(BCC) Induced by Cisplatin
下载PDF
导出
摘要 目的:研究细胞毒类化疗药——顺铂诱导人颊癌细胞凋亡发生的规律以及凋亡分子Apo-1的表达。探讨口腔癌化疗的细胞凋亡机制。方法:以建株人颊癌细胞系BcaCD885为对象,采用光镜、电镜以及流式细胞术等手段观察顺铂诱导颊癌细胞凋亡的形态特征及规律,同时检测顺铂对颊癌细胞Apo-1表达的影响。结果:顺铂作用后的颊癌细胞出现典型的凋亡细胞形态学特征;顺铂诱导颊癌细胞凋亡呈现时间及剂量依赖性效应关系;顺铂能上调颊癌细胞Apo-1的表达。结论:细胞凋亡可能是顺铂杀灭颊癌细胞的重要机制。 Objective: To study apoptotic characteristics and expression of apoptosis molecule Apo 1 (Fas, CD\-\{95\}) on buccal carcinoma cell (BCC) induced by cytotoxic drug cisplatin and exploit the apoptotic mechanisms of oral cancer chemotherapy. Methods: Human BCC line BcaCD885 was used as in vitro study object. Morphological features of apoptotic BCC induced by cisplatin were observed by use of lightmicroscopy and electronmicroscopy, meanwhile, apoptotic rates (AR) were analysed by the flow cytometry. Results: ①Condensation and crack of nucleus and apoptotic bodies appeared in apoptotic BCC; ②There existed time and dosage dependent AR, and AR were respectively 5 4%, 7 4%, 9 4%, 20 3% and 22 6% after BCC had been acted by 15 μg/ml cisplatin for 2,6,12 and 24 hours, moreover, there was significantly difference (P<0 01) among the 12 hour group, the 24 hour group and the control group; ③Cell cycle of BCC was apparently arrested at G\-0/G\-1 by cisplatin (P<0 05); ④Apo 1 expression of BCC were enhanced 58% and 62% respectively after it was induced by 25 μg/ml cisplatin for 18 and 42 hours (P<0 05). Conclusion: Apoptosis may be an important mechanism of BCC killed by cisplatin, and Apo 1 may play a role in the process of apoptosis induced by chemotherapy drugs.\;
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 1999年第4期300-303,I013,共4页 West China Journal of Stomatology
关键词 顺铂 颊癌细胞 细胞凋亡 APO-1 buccal carcinoma cell\ \ apoptosis\ \ cisplatin\ \ apoptotic molecule
  • 相关文献

参考文献1

二级参考文献3

  • 1袁淑兰,中华肿瘤杂志,1995年,17卷,6期,424页
  • 2傅兴生,中华病理学杂志,1993年,23卷,1期,50页
  • 3Wu W,Am J Chin Med,1991年,19卷,34期,207页

共引文献60

同被引文献23

  • 1杨纯正.肿瘤耐药研究进展及逆转对策[J].中华血液学杂志,1997,18(2):59-60. 被引量:29
  • 2Sato T, Irie S, Kitada S, et al. FAP-1: a protein tyrosine phosphatase that associates with Fas/APO-1 (CD95) [J]. Science, 1995,268:411-415.
  • 3Lee SH, Shin MS, Park WS, et al. Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues[J]. APMIS, 1999,107:1101-1108.
  • 4Hendrik U, Marie LK, Anna T, et al. FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis [J]. Journal of Cell Science, 2001,114 :2735-2746.
  • 5Myc A, Arscott PL, Bretz JD, et al. Characterization of FAP1 expression and function in thyroid follicular cells [J]. Endocrinology, 1999,140:5431-5434.
  • 6Micheau O, Solary E, Hammann A, et al. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs[J]. J Biol Chem, 1999,274:7987-7992.
  • 7Yanagisawa J, Takahashi M, Kanki H, et al. The molecular interaction of Fas and FAP-1 : a tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis[J]. J Biol Chem, 1997,272:8539-8545.
  • 8Mansouri A,Henle KJ, Benson AM,et al. Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Cancer Res, 1989,49:2 674.
  • 9Poliseno L, Mariani L, Collecchi P, et al. Bcl2-negative MCF7 cells overexpress P53:implications for the cell cycle and sensitivity to cytotoxic drugs. Cancer Chemother Pharmacol, 2002,50 ( 2 ) : 127.
  • 10Eder JP, Chan VT. Ng SW,et al. DNA topoisomerase Ⅱ alpha expression is associated with alkylating agent resistance.Cancer Research, 1995, 55(24) :6 109.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部